Movement Alert｜True Health Medical-B Falls 5.99% in Regular Trading, Post-IPO Rally Exceeding 200% Triggers Continued Pullback

Market Focus07-06

On July 6, True Health Medical-B fell 5.99% in regular trading, trading at 385.2 HKD/share, with turnover of HKD 2.4179 million. The stock continues to face selling pressure following its extraordinary post-IPO surge.

The company listed on the Hong Kong Stock Exchange on June 30 at an offer price of 126.2 HKD, closing its debut session at 400 HKD — a gain exceeding 217%. The short-term cumulative gain surpassed 200%, and on July 3 the stock already experienced a notable intraday pullback exceeding 7%. Profit-taking continues to weigh on the shares amid elevated valuations.

Fundamentally, the company remains in early-stage commercialization. Its 2025 revenue was approximately RMB 12.18 million, with a net loss of approximately RMB 90.13 million and cumulative losses reaching RMB 1.537 billion. The extreme valuation premium relative to its current financials is intensifying selling pressure from short-term holders locking in gains.

The company is principally engaged in the research, development, and commercialization of percutaneous puncture surgical robots and ablation surgical robots in China.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1152703424?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-06 09:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1152703424","market":"us","top_or_hot":-1,"title":"Movement Alert｜True Health Medical-B Falls 5.99% in Regular Trading, Post-IPO Rally Exceeding 200% Triggers Continued Pullback","media":"Market Focus","content":"<p><p>On July 6, True Health Medical-B fell 5.99% in regular trading, trading at 385.2 HKD/share, with turnover of HKD 2.4179 million. The stock continues to face selling pressure following its extraordinary post-IPO surge.</p><p>The company listed on the Hong Kong Stock Exchange on June 30 at an offer price of 126.2 HKD, closing its debut session at 400 HKD — a gain exceeding 217%. The short-term cumulative gain surpassed 200%, and on July 3 the stock already experienced a notable intraday pullback exceeding 7%. Profit-taking continues to weigh on the shares amid elevated valuations.</p><p>Fundamentally, the company remains in early-stage commercialization. Its 2025 revenue was approximately RMB 12.18 million, with a net loss of approximately RMB 90.13 million and cumulative losses reaching RMB 1.537 billion. The extreme valuation premium relative to its current financials is intensifying selling pressure from short-term holders locking in gains.</p><p>The company is principally engaged in the research, development, and commercialization of percutaneous puncture surgical robots and ablation surgical robots in China.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜True Health Medical-B Falls 5.99% in Regular Trading, Post-IPO Rally Exceeding 200% Triggers Continued Pullback</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜True Health Medical-B Falls 5.99% in Regular Trading, Post-IPO Rally Exceeding 200% Triggers Continued Pullback\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-06 09:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 6, True Health Medical-B fell 5.99% in regular trading, trading at 385.2 HKD/share, with turnover of HKD 2.4179 million. The stock continues to face selling pressure following its extraordinary post-IPO surge.</p><p>The company listed on the Hong Kong Stock Exchange on June 30 at an offer price of 126.2 HKD, closing its debut session at 400 HKD — a gain exceeding 217%. The short-term cumulative gain surpassed 200%, and on July 3 the stock already experienced a notable intraday pullback exceeding 7%. Profit-taking continues to weigh on the shares amid elevated valuations.</p><p>Fundamentally, the company remains in early-stage commercialization. Its 2025 revenue was approximately RMB 12.18 million, with a net loss of approximately RMB 90.13 million and cumulative losses reaching RMB 1.537 billion. The extreme valuation premium relative to its current financials is intensifying selling pressure from short-term holders locking in gains.</p><p>The company is principally engaged in the research, development, and commercialization of percutaneous puncture surgical robots and ablation surgical robots in China.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02697","symbol_name":"真健康医疗-B","start_time":0,"source_url":"","article_id":"1152703424","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1152703424","pubTimestamp":1783302153,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 6, True Health Medical-B fell 5.99% in regular trading, trading at 385.2 HKD/share, with turnover of HKD 2.4179 million. The stock continues to face selling pressure following its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02697":"真健康医疗-B"},"translate_title":"异动快讯|真健康医疗-B常规交易跌5.99%IPO后升势超200%触发持续回调","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02697":1},"content_text":"On July 6, True Health Medical-B fell 5.99% in regular trading, trading at 385.2 HKD/share, with turnover of HKD 2.4179 million. The stock continues to face selling pressure following its extraordinary post-IPO surge.The company listed on the Hong Kong Stock Exchange on June 30 at an offer price of 126.2 HKD, closing its debut session at 400 HKD — a gain exceeding 217%. The short-term cumulative gain surpassed 200%, and on July 3 the stock already experienced a notable intraday pullback exceeding 7%. Profit-taking continues to weigh on the shares amid elevated valuations.Fundamentally, the company remains in early-stage commercialization. Its 2025 revenue was approximately RMB 12.18 million, with a net loss of approximately RMB 90.13 million and cumulative losses reaching RMB 1.537 billion. The extreme valuation premium relative to its current financials is intensifying selling pressure from short-term holders locking in gains.The company is principally engaged in the research, development, and commercialization of percutaneous puncture surgical robots and ablation surgical robots in China.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1152703424","isCrawlerRequest":true}